Net Cash Provided by (Used in) Operating Activities in USD of Akari Therapeutics Plc from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Akari Therapeutics Plc quarterly and annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2010 to Q1 2025.
  • Akari Therapeutics Plc Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $2,150,000, a 47% increase year-over-year.
  • Akari Therapeutics Plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was $12,552,000, a 24% increase from 2023.
  • Akari Therapeutics Plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was $16,432,000, a 120% decline from 2022.
  • Akari Therapeutics Plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was $7,485,625, a 60% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Akari Therapeutics Plc Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,150,000 +$1,894,000 +47% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $4,044,000 +$836,000 +17% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $4,880,000 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2020 $7,739,656 -$7,968,600 -3481% 01 Jan 2020 31 Mar 2020 20-F 21 Apr 2021 2020 FY
Q1 2019 $228,944 01 Jan 2019 31 Mar 2019 20-F 21 Apr 2021 2020 FY
Q1 2016 $7,440,576 -$5,452,098 -274% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q1 2015 $1,988,478 +$59,522 +2.9% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q1 2014 $2,048,000 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1

Akari Therapeutics Plc Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $12,552,000 +$3,880,000 +24% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $16,432,000 -$8,946,375 -120% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $7,485,625 +$11,360,903 +60% 01 Jan 2022 31 Dec 2022 8-K 06 Sep 2024
2021 $18,846,528 -$1,896,120 -11% 01 Jan 2021 31 Dec 2021 20-F 01 May 2023 2022 FY
2020 $16,950,408 -$4,032,095 -31% 01 Jan 2020 31 Dec 2020 20-F 01 May 2023 2022 FY
2019 $12,918,313 +$9,855,695 +43% 01 Jan 2019 31 Dec 2019 20-F 16 May 2022 2021 FY
2018 $22,774,008 +$8,824,701 +28% 01 Jan 2018 31 Dec 2018 20-F 21 Apr 2021 2020 FY
2017 $31,598,709 -$6,974,174 -28% 01 Jan 2017 31 Dec 2017 20-F 31 Mar 2020 2019 FY
2016 $24,624,535 -$19,658,952 -396% 01 Jan 2016 31 Dec 2016 20-F 23 Apr 2019 2018 FY
2015 $4,965,583 -$3,488,759 -236% 01 Jan 2015 31 Dec 2015 20-F 18 Jul 2018 2017 FY
2014 $1,476,824 +$3,973,176 +73% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
2013 $5,450,000 -$3,316,000 -155% 01 Jan 2013 31 Dec 2013 10-K 11 Feb 2015 2014 FY
2012 $2,134,000 -$1,126,000 -112% 01 Jan 2012 31 Dec 2012 10-K 11 Feb 2015 2014 FY
2011 $1,008,000 -$642,000 -175% 01 Jan 2011 31 Dec 2011 20-F 24 Mar 2014 2013 FY
2010 $366,000 01 Jan 2010 31 Dec 2010 20-F/A 19 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.